Hachiya, Y., Uruha, A., Kasai-Yoshida, E., Shimoda, K., Satoh-Shirai, I., Kumada, S., et al. (2013) Rituximab Ameliorates Anti-N-Methyl-D-Aspartate Receptor Encephalitis by Removal of Short-Lived Plasmablasts. Journal of Neuroimmunology, 265, 128-130.
http://dx.doi.org/10.1016/j.jneuroim.2013.09.017

has been cited by the following article:

• TITLE: Anti N-Methyl-D-Aspartate (NMDA) Receptor Encephalitis with Frustrated Diagnosis Course: A Case Report

  AUTHORS: Huanquan Liao, Hongyan Zhou, Ling Chen

  KEYWORDS: Anti-NMDA Receptor Encephalitis, Ovarian Teratoma

  JOURNAL NAME: World Journal of Neuroscience, Vol.5 No.5, November 4, 2015

  ABSTRACT: Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis is a rare disease with uncertain etiology and pathogenesis that affects young women. Its diagnosis can be delayed because of the nonspecific neuropsychiatric symptoms in the foreground. This article describes the details of a recent complicated case of a patient with this condition which is related to an ovarian teratoma. Correct diagnostic and prompt treatment of anti-NMDA receptor encephalitis remains a serious clinical challenge due to its unspecific manifestations and varying response to treatments. The information will be of interest to clinicians working with encephalitis patients.